TAK-653 (Osavampator) Research Standard

TAK-653 (Osavampator / NBI-1065845) is a synthetic pyrazinothiadiazine dioxide that functions as a positive allosteric modulator (PAM) of the AMPA-type glutamate receptor. By design, TAK-653 serves as a “glutamate-dependent” potentiator; it stabilizes the active conformation of the AMPA receptor specifically in the presence of endogenous glutamate, with minimal intrinsic agonist activity. This specific gating mechanism provides a distinct safety margin compared to earlier high-efficacy AMPA PAMs, which were historically associated with convulsive liability. In laboratory research, TAK-653 is a vital tool for studying the intricacies of AMPA receptor electrophysiology and the modulation of glutamatergic neurotransmission.

Technical Specifications

Mechanism of Action & Research Context

TAK-653 differentiates itself from first-generation AMPA potentiators through its unique interaction with the glutamate-binding pathway.

• Glutamate-Dependent Gating: The compound potentiates receptor currents only when endogenous glutamate is already bound to the receptor. This minimizes the risk of receptor over-activation (excitotoxicity) that plagued earlier, less-selective PAMs.

• Structural Interaction: Molecular modeling localizes the activity of TAK-653 to the Ser743 residue within the GluA1 subunit of the AMPA receptor.

• Minimal Intrinsic Agonism: Because it acts as a strictly agonist-dependent potentiator, it offers a refined chemical probe for investigating the physiological tuning of excitatory synapses without confounding seizure-related variables.

Research Applications

TAK-653 is an essential reagent for investigating the dynamics of the central nervous system’s excitatory pathways.

Primary fields of in vitro laboratory investigation include:

• AMPA Receptor Electrophysiology: Studying allosteric modulation and the kinetics of receptor current potentiation.

• Ca2+ Influx Assays: Utilizing hGluA1i-expressing cell lines to measure receptor sensitivity and response thresholds.

• Glutamate-Dependence & Desensitization: Investigating how the compound regulates desensitization kinetics under conditions of varying glutamate concentration.

• Comparative Reference: Providing a benchmark against high-efficacy AMPA PAMs to differentiate between therapeutic potential and convulsive liability in metabolic and neurobiological research models.

Storage & Handling Guidelines

Store at controlled room temperature. Keep tightly closed. Liquid formats: do not refrigerate or freeze. Cold storage may cause the solution to cloud or precipitate. If this occurs, return to room temperature and mix until clear.

Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.